Eying Clinical Trials, Shattuck Labs Adds $46M for Immunotherapy R&D

… “know-how” in June 2016 from Durham, NC-based Heat (NASDAQ: HTBX), another immunotherapy drug developer, according to a securities filing. …read more

Read more here:: Eying Clinical Trials, Shattuck Labs Adds $46M for Immunotherapy R&D